We have previously shown that metabolomic profiling of plasma samples using high performance liquid chromatography coupled with electrochemical coulometric array detection (LCECA) distinguished patients with sporadic PD from those with LRRK2-related PD (LRRK2-PD) and even separated asymptomatic mutation carriers from family members without the mutation [12]. Here, LRRK2 is linked to Parkinson disease.